Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells

Autor: Aras, Sahra, Ozdemir, Beril Su, Arisan, Elif Damla, Rencuzogullari, Ozge, Ozfiliz, Pelin, Yerlikaya, Pinar Obakan, Gurkan, Ajda Coker, Unsal, Narcin Palavan
Zdroj: In Journal of Biotechnology 30 August 2017 256 Supplement:S31-S31
Databáze: ScienceDirect